In conclusion, our study indicates that UHRF1 is overexpressed in NSCLC, especially in SCC, but the up‐regulated UHRF1 only contributes to ADC patients' survival by activating cell cycle pathway. The gene discussed is UHRF1; the disease is non-small cell lung carcinoma.